These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22475870)

  • 21. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.
    de Vries JF; Falkenburg JH; Willemze R; Barge RM
    Haematologica; 2006 Jul; 91(7):912-9. PubMed ID: 16818278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
    Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT
    Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
    McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
    Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells.
    Mowery YM; Weinberg JB; Kennedy MN; Bond KM; Moore JO; Lanasa MC; Gockerman JP; Diehl LF; Pizzo SV; Cianciolo GJ; Friedman DR
    Leukemia; 2010 Sep; 24(9):1580-7. PubMed ID: 20613784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
    Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
    Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia.
    Vogler M; Butterworth M; Majid A; Walewska RJ; Sun XM; Dyer MJ; Cohen GM
    Blood; 2009 Apr; 113(18):4403-13. PubMed ID: 19008458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells.
    You KR; Shin MN; Park RK; Lee SO; Kim DG
    Hepatology; 2001 Dec; 34(6):1119-27. PubMed ID: 11732001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells.
    Schroeder CP; Kadara H; Lotan D; Woo JK; Lee HY; Hong WK; Lotan R
    Cancer Res; 2006 Oct; 66(19):9762-70. PubMed ID: 17018636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.
    Zheng L; Yang W; Zhang C; Ding WJ; Zhu H; Lin NM; Wu HH; He QJ; Yang B
    Cancer Lett; 2011 Oct; 309(1):27-36. PubMed ID: 21664043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
    de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A
    J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vinblastine rapidly induces NOXA and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737.
    Bates DJ; Danilov AV; Lowrey CH; Eastman A
    Mol Cancer Ther; 2013 Aug; 12(8):1504-14. PubMed ID: 23723123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of Rac in fenretinide-induced apoptosis.
    Kadara H; Tahara E; Kim HJ; Lotan D; Myers J; Lotan R
    Cancer Res; 2008 Jun; 68(11):4416-23. PubMed ID: 18519704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.
    Yoon JY; Ishdorj G; Graham BA; Johnston JB; Gibson SB
    Apoptosis; 2014 Jan; 19(1):191-200. PubMed ID: 24057147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
    Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J
    Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased level of the p67phox subunit of NADPH oxidase by 4HPR in head and neck squamous carcinoma cells.
    Kim HJ; Oridate N; Lotan R
    Int J Oncol; 2005 Sep; 27(3):787-90. PubMed ID: 16077929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
    Suzuki S; Higuchi M; Proske RJ; Oridate N; Hong WK; Lotan R
    Oncogene; 1999 Nov; 18(46):6380-7. PubMed ID: 10597238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
    Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
    Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
    Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment.
    Crassini K; Shen Y; Stevenson WS; Christopherson R; Ward C; Mulligan SP; Best OG
    Br J Haematol; 2018 Aug; 182(3):360-372. PubMed ID: 29767411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.